{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:56:07Z","timestamp":1794639367905,"version":"4.9.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014107","name":"Stichting TSC Fonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014107","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Tuberous sclerosis complex (TSC) is a rare and complex genetic disorder, associated with tumor growth in various organ systems, epilepsy, and a range of neuropsychiatric manifestations including intellectual disability. With improving patient-centered care and targeted therapies, patient-reported outcome measures (PROMs) are needed to measure the impact of TSC manifestations on daily functioning. The aim of this study was to develop a TSC-specific PROM for adults that captures the impact of TSC on physical functions, mental functions, activity and participation, and the social support individuals with TSC receive, called the TSC-PROM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>COSMIN methodology was used to develop a self-reported and proxy-reported version. Development and validation consisted of the following studies: PROM development, content validity, structural validity, internal consistency, and construct validity. The International Classification of Functioning and Disability was used as a framework. Content validity was examined by a multidisciplinary expert group and cognitive interview study. Structural and construct validity, and internal consistency were examined in a large cohort, using confirmatory factor analysis, hypotheses testing, and Cronbach\u2019s alpha.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The study resulted in an 82-item self version and 75-item proxy version of the TSC-PROM with four subscales (physical functions 18 and 19 items, mental functions 37 and 28 items, activities and participation 13 and 14 items, social support 13 items, for self version and proxy version respectively). Sufficient results were found for structural validity with sufficient unidimensionality for each subscale. With regard to construct validity, 82% of the hypotheses were met for the self version and 59% for the proxy version. The PROM showed good internal consistency (Cronbach\u2019s alpha 0.78\u20130.97).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We developed a PROM for adults with TSC, named TSC-PROM, showing sufficient evidence for reliability and validity that can be used in clinical and research settings to systematically gain insight into their experiences. It is the first PROM in TSC that addresses the impact of specific TSC manifestations on functioning, providing a valuable, patient-centered addition to the current clinical outcomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-023-03012-4","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T10:02:24Z","timestamp":1691488944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Understanding the impact of tuberous sclerosis complex: development and validation of the TSC-PROM"],"prefix":"10.1186","volume":"21","author":[{"given":"Annelieke R.","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel A. J.","family":"Luijten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotte","family":"Haverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendela L.","family":"de Ranitz-Greven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 B.","family":"Rietman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leontine W.","family":"ten Hoopen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C. G.","family":"de Graaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claire","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanjala","family":"Gipson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie K.","family":"Capal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petrus J.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnies M.","family":"van Eeghen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,8]]},"reference":[{"key":"3012_CR1","doi-asserted-by":"crossref","unstructured":"Northrup H, Krueger DA, Roberds S, Smith K, Sampson J, Korf B, et al. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013;49(4):243\u201354.","DOI":"10.1016\/j.pediatrneurol.2013.08.001"},{"key":"3012_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2021.07.011","volume":"123","author":"H Northrup","year":"2021","unstructured":"Northrup H, Aronow ME, Bebin EM, Bissler J, Darling TN, de Vries PJ, et al. Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations. Pediatr Neurol. 2021;123:50\u201366.","journal-title":"Pediatr Neurol"},{"issue":"7","key":"3012_CR3","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S1474-4422(15)00069-1","volume":"14","author":"P Curatolo","year":"2015","unstructured":"Curatolo P, Moavero R, de Vries PJ. Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol. 2015;14(7):733\u201345.","journal-title":"Lancet Neurol"},{"issue":"1","key":"3012_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.pediatrneurol.2014.10.004","volume":"52","author":"PJ De Vries","year":"2015","unstructured":"De Vries PJ, Whittemore VH, Leclezio L, Byars AW, Dunn D, Ess KC, et al. Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND checklist. Pediatr Neurol. 2015;52(1):25\u201335.","journal-title":"Pediatr Neurol"},{"issue":"1","key":"3012_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s11689-022-09423-3","volume":"14","author":"S Vanclooster","year":"2022","unstructured":"Vanclooster S, Bissell S, van Eeghen AM, Chambers N, De Waele L, Byars AW, et al. The research landscape of tuberous sclerosis complex\u2013associated neuropsychiatric disorders (TAND)\u2014a comprehensive scoping review. J Neurodev Disord. 2022;14(1):13.","journal-title":"J Neurodev Disord"},{"issue":"4","key":"3012_CR6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/epi4.12365","volume":"4","author":"M Vergeer","year":"2019","unstructured":"Vergeer M, de Ranitz-Greven WL, Neary MP, Ionescu-Ittu R, Emond B, Sheng Duh M, et al. Epilepsy, impaired functioning, and quality of life in patients with tuberous sclerosis complex. Epilepsia Open. 2019;4(4):581\u201392.","journal-title":"Epilepsia Open"},{"issue":"2","key":"3012_CR7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1177\/1362361313517053","volume":"19","author":"BFC Van Heijst","year":"2015","unstructured":"Van Heijst BFC, Geurts HM. Quality of life in autism across the lifespan: a meta-analysis. Autism. 2015;19(2):158\u201367.","journal-title":"Autism"},{"issue":"2","key":"3012_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11060-015-1725-1","volume":"122","author":"AM Vranceanu","year":"2015","unstructured":"Vranceanu AM, Merker VL, Park ER, Plotkin SR. Quality of life among children and adolescents with neurofibromatosis 1: a systematic review of the literature. J Neuro-Oncol. 2015;122(2):219\u201328.","journal-title":"J Neuro-Oncol"},{"key":"3012_CR9","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3389\/fphar.2018.00964","volume":"9","author":"PJ de Vries","year":"2018","unstructured":"de Vries PJ, Franz DN, Curatolo P, Nabbout R, Neary M, Herbst F, et al. Measuring health-related quality of life in tuberous sclerosis complex - psychometric evaluation of three instruments in individuals with refractory epilepsy. Front Pharmacol. 2018;9:964.","journal-title":"Front Pharmacol."},{"key":"3012_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.yebeh.2018.03.012","volume":"83","author":"P Both","year":"2018","unstructured":"Both P, ten Holt L, Mous S, Patist J, Rietman A, Dieleman G, et al. Tuberous sclerosis complex: concerns and needs of patients and parents from the transitional period to adulthood. Epilepsy Behav. 2018;83:13\u201321.","journal-title":"Epilepsy Behav"},{"issue":"1","key":"3012_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s11689-020-09327-0","volume":"12","author":"PJ De Vries","year":"2020","unstructured":"De Vries PJ, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P, et al. Natural clusters of tuberous sclerosis complex (TSC)-associated neuropsychiatric disorders (TAND): new findings from the TOSCA TAND research project. J Neurodev Disord. 2020;12(1):24.","journal-title":"J Neurodev Disord"},{"issue":"5","key":"3012_CR12","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/ajmg.a.38680","volume":"176","author":"AB Rietman","year":"2018","unstructured":"Rietman AB, van Helden H, Both PH, Taal W, Legerstee JS, van Staa AL, et al. Worries and needs of adults and parents of adults with neurofibromatosis type 1. Am J Med Genet Part A. 2018;176(5):1150\u201360.","journal-title":"Am J Med Genet Part A"},{"issue":"4","key":"3012_CR13","first-page":"631","volume":"27","author":"YJ Ju","year":"2017","unstructured":"Ju YJ, Kim TH, Han KT, Lee HJ, Kim W, Lee SA, et al. Association between unmet healthcare needs and health-related quality of life: a longitudinal study. Eur J Public Health. 2017;27(4):631\u20137.","journal-title":"Eur J Public Health"},{"issue":"1","key":"3012_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12955-016-0575-7","volume":"15","author":"MR van Walsem","year":"2017","unstructured":"van Walsem MR, Howe EI, Ruud GA, Frich JC, Andelic N. Health-related quality of life and unmet healthcare needs in Huntington\u2019s disease. Health Qual Life Outcomes. 2017;15(1):6.","journal-title":"Health Qual Life Outcomes"},{"issue":"Pt A","key":"3012_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yebeh.2017.02.007","volume":"70","author":"JK Capal","year":"2017","unstructured":"Capal JK, Bernardino-Cuesta B, Horn PS, Murray D, Byars AW, Bing NM, et al. Influence of seizures on early development in tuberous sclerosis complex. Epilepsy Behav. 2017;70(Pt A):245\u201352.","journal-title":"Epilepsy Behav"},{"key":"3012_CR16","doi-asserted-by":"crossref","unstructured":"Boylan LS, Flint LA, Labovitz DL, Jackson SC, Starner K, Devinsky O. Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology. 2004;62(2):258\u201361.","DOI":"10.1212\/01.WNL.0000103282.62353.85"},{"issue":"23","key":"3012_CR17","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1212\/WNL.0000000000003400","volume":"87","author":"DA Krueger","year":"2016","unstructured":"Krueger DA, Wilfong AA, Mays M, Talley CM, Agricola K, Tudor C, et al. Long-term treatment of epilepsy with everolimus in tuberous sclerosis. Neurology. 2016;87(23):2408\u201315.","journal-title":"Neurology"},{"issue":"1","key":"3012_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s13023-017-0739-5","volume":"12","author":"JW Frew","year":"2017","unstructured":"Frew JW, Davidson M, Murrell DF. Disease-specific health related quality of life patient reported outcome measures in Genodermatoses: a systematic review and critical evaluation. Orphanet J Rare Dis. 2017;12(1):189.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"3012_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11136-007-9295-0","volume":"17","author":"JM Valderas","year":"2008","unstructured":"Valderas JM, Kotzeva A, Espallargues M, Guyatt G, Ferrans CE, Halyard MY, et al. The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature. Qual Life Res. 2008;17(2):179\u201393.","journal-title":"Qual Life Res"},{"key":"3012_CR20","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/1472-6882-11-136","volume":"11","author":"JJ Thompson","year":"2011","unstructured":"Thompson JJ, Kelly KL, Ritenbaugh C, Hopkins AL, Sims CM, Coons SJ. Developing a patient-centered outcome measure for complementary and alternative medicine therapies II: refining content validity through cognitive interviews. BMC Complement Altern Med. 2011;11:136.","journal-title":"BMC Complement Altern Med"},{"key":"3012_CR21","doi-asserted-by":"crossref","unstructured":"Gibbons C, Porter I, Gon\u00e7alves-Bradley DC, Stoilov S, Ricci-Cabello I, Tsangaris E, et al. Routine provision of feedback from patient-reported outcome measurements to healthcare providers and patients in clinical practice. Cochrane Database Syst Rev. 2021;10:CD011589.","DOI":"10.1002\/14651858.CD011589.pub2"},{"key":"3012_CR22","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2147\/PROM.S156279","volume":"9","author":"R Mercieca-Bebber","year":"2018","unstructured":"Mercieca-Bebber R, King MT, Calvert MJ, Stockler MR, Friedlander M. The importance of patient-reported outcomes in clinical trials and strategies for future optimization. Patient Relat Outcome Meas. 2018;9:353\u201367.","journal-title":"Patient Relat Outcome Meas"},{"issue":"8","key":"3012_CR23","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","volume":"39","author":"JW Varni","year":"2001","unstructured":"Varni JW, Seid M, Kurtin PS. PedsQLTM 4.0: reliability and validity of the pediatric quality of life inventoryTM Version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39(8):800\u201312.","journal-title":"Med Care"},{"issue":"24","key":"3012_CR24","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1097\/00007632-200012150-00008","volume":"25","author":"JE Ware","year":"2000","unstructured":"Ware JE. SF-36 health survey update. Spine. 2000;25(24):3130\u20139.","journal-title":"Spine"},{"issue":"1","key":"3012_CR25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1572-0241.2003.07158.x","volume":"98","author":"CJ Bijkerk","year":"2003","unstructured":"Bijkerk CJ, De Wit NJ, Muris JWM, Jones RH, Knottnerus JA, Hoes AW. Outcome measures in irritable bowel syndrome: comparison of psychometric and methodological characteristics. Am J Gastroenterol. 2003;98(1):122\u20137.","journal-title":"Am J Gastroenterol"},{"key":"3012_CR26","doi-asserted-by":"crossref","unstructured":"Lee EH, Kwon O, Hahm KB, Kim WH, Kim J Il, Cheung DY, et al. Irritable bowel syndrome-specific health-related quality of life instrument: development and psychometric evaluation. Health Qual Life Outcomes. 2016;14(1):1\u20139.","DOI":"10.1186\/s12955-016-0423-9"},{"issue":"1","key":"3012_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s42466-021-00130-3","volume":"3","author":"JP Z\u00f6llner","year":"2021","unstructured":"Z\u00f6llner JP, Conradi N, Sauter M, Knuf M, Knake S, Kurlemann G, et al. Quality of life and its predictors in adults with tuberous sclerosis complex (TSC): a multicentre cohort study from Germany. Neurol Res Pract. 2021;3(1):35.","journal-title":"Neurol Res Pract"},{"key":"3012_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/8904_2017_11","volume":"37","author":"NA Zeltner","year":"2017","unstructured":"Zeltner NA, Baumgartner MR, Bondarenko A, Ensenauer R, Karall D, K\u00f6lker S, et al. Development and psychometric evaluation of the metabQoL 1.0: a quality of life questionnaire for paediatric patients with intoxication-type inborn errors of metabolism. JIMD Rep. 2017;37:27\u201335.","journal-title":"JIMD Rep"},{"issue":"3","key":"3012_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/nau.20634","volume":"28","author":"S Srikrishna","year":"2009","unstructured":"Srikrishna S, Robinson D, Cardozo L, Gonzalez J. Is there a discrepancy between patient and physician quality of life assessment? Neurourol Urodyn. 2009;28(3):179\u201382.","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"3012_CR30","first-page":"492","volume":"89","author":"MG Aman","year":"1985","unstructured":"Aman MG, Singh NN, Stewart AW, Field CJ. Psychometric characteristics of the aberrant behavior checklist. Am J Ment Defic. 1985;89(5):492\u2013502.","journal-title":"Am J Ment Defic"},{"issue":"1","key":"3012_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s11689-016-9167-4","volume":"8","author":"D Hessl","year":"2016","unstructured":"Hessl D, Sansone SM, Berry-Kravis E, Riley K, Widaman KF, Abbeduto L, et al. The NIH Toolbox Cognitive Battery for intellectual disabilities: three preliminary studies and future directions. J Neurodev Disord. 2016;8(1):35.","journal-title":"J Neurodev Disord"},{"issue":"1","key":"3012_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s41687-020-00219-4","volume":"4","author":"S Cruz Rivera","year":"2020","unstructured":"Cruz Rivera S, McMullan C, Jones L, Kyte D, Slade A, Calvert M. The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders. J Patient-Reported Outcomes. 2020;4(1):51.","journal-title":"J Patient-Reported Outcomes"},{"key":"3012_CR33","doi-asserted-by":"crossref","unstructured":"De Vet HCW, Terwee CB, Mokkink LB, Knol DL. Measurement in medicine: a practical guide. Cambridge university press. 2011.","DOI":"10.1017\/CBO9780511996214"},{"issue":"5","key":"3012_CR34","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s11136-018-1829-0","volume":"27","author":"CB Terwee","year":"2018","unstructured":"Terwee CB, Prinsen CAC, Chiarotto A, Westerman MJ, Patrick DL, Alonso J, et al. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study. Qual Life Res. 2018;27(5):1159\u201370.","journal-title":"Qual Life Res"},{"issue":"5","key":"3012_CR35","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1055\/s-0030-1269906","volume":"41","author":"DN Franz","year":"2010","unstructured":"Franz DN, Bissler JJ, McCormack FX. Tuberous sclerosis complex: neurological, renal and pulmonary manifestations. Neuropediatrics. 2010;41(5):199\u2013208.","journal-title":"Neuropediatrics"},{"key":"3012_CR36","doi-asserted-by":"crossref","unstructured":"Hasbani DM, Crino PB. Tuberous sclerosis complex. Handb Clin Neurol. 2018;148:813\u201322.","DOI":"10.1016\/B978-0-444-64076-5.00052-1"},{"issue":"2","key":"3012_CR37","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ejpn.2015.11.011","volume":"20","author":"C Kingswood","year":"2016","unstructured":"Kingswood C, Bolton P, Crawford P, Harland C, Johnson SR, Sampson JR, et al. The clinical profile of tuberous sclerosis complex (TSC) in the United Kingdom: a retrospective cohort study in the Clinical Practice Research Datalink (CPRD). Eur J Paediatr Neurol. 2016;20(2):296\u2013308.","journal-title":"Eur J Paediatr Neurol"},{"issue":"1","key":"3012_CR38","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.pediatrneurol.2014.10.006","volume":"52","author":"L Leclezio","year":"2015","unstructured":"Leclezio L, Jansen A, Whittemore VH, De Vries PJ. Pilot validation of the tuberous sclerosis-associated neuropsychiatric disorders (TAND) checklist. Pediatr Neurol. 2015;52(1):16\u201324.","journal-title":"Pediatr Neurol"},{"key":"3012_CR39","unstructured":"World Health Organization. Towards a common language for functioning, disability and health ICF. International Classification. 2002. Available from: https:\/\/www.who.int\/publications\/m."},{"issue":"3","key":"3012_CR40","doi-asserted-by":"publisher","first-page":"353","DOI":"10.4300\/JGME-D-13-00154.1","volume":"5","author":"GB Willis","year":"2013","unstructured":"Willis GB, Artino AR. What do our respondents think we\u2019re asking? Using cognitive interviewing to improve medical education surveys. J Grad Med Educ. 2013;5(3):353\u20136.","journal-title":"J Grad Med Educ"},{"issue":"3","key":"3012_CR41","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1023\/A:1023254226592","volume":"12","author":"D Collins","year":"2003","unstructured":"Collins D. Pretesting survey instruments: an overview of cognitive methods. Qual Life Res. 2003;12(3):229\u201338.","journal-title":"Qual Life Res"},{"issue":"4","key":"3012_CR42","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s11136-016-1426-z","volume":"26","author":"DE Ediebah","year":"2017","unstructured":"Ediebah DE, Reijneveld JC, Taphoorn MJB, Coens C, Zikos E, Aaronson NK, et al. Impact of neurocognitive deficits on patient\u2013proxy agreement regarding health-related quality of life in low-grade glioma patients. Qual Life Res. 2017;26(4):869\u201380.","journal-title":"Qual Life Res"},{"key":"3012_CR43","unstructured":"Achenbach TM, Rescorla LA. Manual for the ASEBA Adult Forms & Profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth & Families. 2003."},{"key":"3012_CR44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.comppsych.2017.03.006","volume":"79","author":"TM Achenbach","year":"2017","unstructured":"Achenbach TM, Ivanova MY, Rescorla LA. Empirically based assessment and taxonomy of psychopathology for ages 1\u00bd\u201390+ years: developmental, multi-informant, and multicultural findings. Compr Psychiatry. 2017;79:4\u201318.","journal-title":"Compr Psychiatry"},{"issue":"1","key":"3012_CR45","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1186\/s13023-021-02076-w","volume":"16","author":"PJ de Vries","year":"2021","unstructured":"de Vries PJ, Leclezio L, Gardner-Lubbe S, Krueger D, Sahin M, Sparagana S, et al. Multivariate data analysis identifies natural clusters of tuberous sclerosis complex associated neuropsychiatric disorders (TAND). Orphanet J Rare Dis. 2021;16(1):447.","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"3012_CR46","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S0895-4356(98)00107-3","volume":"51","author":"JE Ware","year":"1998","unstructured":"Ware JE, Kosinski M, Gandek B, Aaronson NK, Apolone G, Bech P, et al. The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. J Clin Epidemiol. 1998;51(11):1159\u201365.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"3012_CR47","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3390\/psych4020021","volume":"4","author":"M Reed","year":"2022","unstructured":"Reed M, Reaume S, Ferro M. Psychometric properties of the Short Form-36 (SF-36) in parents of children with mental illness. Psych. 2022;4(2):247\u201357. https:\/\/doi.org\/10.3390\/psych4020021.","journal-title":"Psych"},{"issue":"6","key":"3012_CR48","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.ejpn.2019.09.006","volume":"23","author":"S Amin","year":"2019","unstructured":"Amin S, Mallick AA, Lux A, O\u2019Callaghan F. Quality of life in patients with tuberous sclerosis complex (TSC). Eur J Paediatr Neurol. 2019;23(6):801\u20137.","journal-title":"Eur J Paediatr Neurol"},{"issue":"1","key":"3012_CR49","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13023-020-01417-5","volume":"15","author":"T Hatano","year":"2020","unstructured":"Hatano T, Ohno Y, Imai Y, Moritake J, Endo K, Tamari M, et al. Improved health-related quality of life in patients treated with topical sirolimus for facial angiofibroma associated with tuberous sclerosis complex. Orphanet J Rare Dis. 2020;15(1):133.","journal-title":"Orphanet J Rare Dis"},{"key":"3012_CR50","unstructured":"Achenbach TM. The Achenbach System of Empirically Based Assessment (ASEBA): Development, Findings, Theory, and Applications. Burlington, VT: University of Vermont Research Center for Children, Youth and Families. 2009."},{"issue":"10","key":"3012_CR51","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1136\/archdischild-2018-316394","volume":"104","author":"CY Fong","year":"2019","unstructured":"Fong CY, Ng K, Kong AN, Ong LC, Rithauddin MA, Thong MK, et al. Quality of life of children with tuberous sclerosis complex. Arch Dis Child. 2019;104(10):972\u20138. https:\/\/doi.org\/10.1136\/archdischild-2018-316394.","journal-title":"Arch Dis Child"},{"issue":"5","key":"3012_CR52","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1055\/s-0039-1693042","volume":"50","author":"D Ebrahimi-Fakhari","year":"2019","unstructured":"Ebrahimi-Fakhari D, Hussong J, Flotats-Bastardas M, Ebrahimi-Fakhari D, Zemlin M, von Gontard A, et al. Tuberous sclerosis complex associated neuropsychiatric disorders and parental stress: findings from a national, prospective TSC surveillance study. Neuropediatrics. 2019;50(5):294\u20139.","journal-title":"Neuropediatrics"},{"issue":"2","key":"3012_CR53","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1212\/WNL.0000000000007749","volume":"93","author":"IE Overwater","year":"2019","unstructured":"Overwater IE, Rietman AB, Mous SE, Bindels-De Heus K, Rizopoulos D, Ten Hoopen LW, et al. A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex. Neurology. 2019;93(2):e200\u20139.","journal-title":"Neurology"},{"issue":"1","key":"3012_CR54","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.yebeh.2010.10.023","volume":"20","author":"AM van Eeghen","year":"2011","unstructured":"van Eeghen AM, Numis AI, Staley BA, Therrien SE, Thibert RL, Thiele EA. Characterizing sleep disorders of adults with tuberous sclerosis complex: a questionnaire-based study and review. Epilepsy Behav. 2011;20(1):68\u201374.","journal-title":"Epilepsy Behav"},{"key":"3012_CR55","doi-asserted-by":"crossref","unstructured":"Rosseel Y. Lavaan: an R package for structural equation modeling. J Stat Softw. 2012;48:1\u201336.","DOI":"10.18637\/jss.v048.i02"},{"issue":"5 SUPPL. 1","key":"3012_CR56","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1097\/01.mlr.0000250483.85507.04","volume":"45","author":"BB Reeve","year":"2007","unstructured":"Reeve BB, Hays RD, Bjorner JB, Cook KF, Crane PK, Teresi JA, et al. Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care. 2007;45(5 SUPPL. 1):S22-31.","journal-title":"Med Care"},{"key":"3012_CR57","unstructured":"Schermelleh-Engel K, Moosbrugger H, M\u00fcller H. Evaluating the fit of structural equation models: tests of significance and descriptive goodness-of-fit measures. MPR-online. 2003;8(2):23\u201374."},{"issue":"6","key":"3012_CR58","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1080\/00223891.2010.496477","volume":"92","author":"SP Reise","year":"2010","unstructured":"Reise SP, Moore TM, Haviland MG. Bifactor models and rotations: exploring the extent to which multidimensional data yield univocal scale scores. J Pers Assess. 2010;92(6):544\u201359.","journal-title":"J Pers Assess"},{"key":"3012_CR59","doi-asserted-by":"crossref","unstructured":"Van Der Ark LA. Mokken scale analysis in R. J Stat Softw. 2007;20(11):1\u201319.","DOI":"10.18637\/jss.v020.i11"},{"issue":"12","key":"3012_CR60","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1212\/01.wnl.0000280578.99900.96","volume":"70","author":"FE Jansen","year":"2008","unstructured":"Jansen FE, Braams O, Vincken KL, Algra A, Anbeek P, Jennekens-Schinkel A, et al. Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations. Neurology. 2008;70(12):908\u201315.","journal-title":"Neurology"},{"issue":"5","key":"3012_CR61","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/ejhg.2011.241","volume":"20","author":"AM Van Eeghen","year":"2012","unstructured":"Van Eeghen AM, Black ME, Pulsifer MB, Kwiatkowski DJ, Thiele EA. Genotype and cognitive phenotype of patients with tuberous sclerosis complex. Eur J Hum Genet. 2012;20(5):510\u20135.","journal-title":"Eur J Hum Genet"},{"key":"3012_CR62","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejpn.2021.10.003","volume":"35","author":"LM Willems","year":"2021","unstructured":"Willems LM, Schubert-Bast S, Grau J, Hertzberg C, Kurlemann G, Wiemer-Kruel A, et al. Health-related quality of life in children and adolescents with tuberous sclerosis complex and their caregivers: a multicentre cohort study from Germany. Eur J Paediatr Neurol. 2021;35:111\u201322.","journal-title":"Eur J Paediatr Neurol"},{"issue":"1","key":"3012_CR63","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jclinepi.2006.03.012","volume":"60","author":"CB Terwee","year":"2007","unstructured":"Terwee CB, Bot SDM, de Boer MR, van der Windt DAWM, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34\u201342.","journal-title":"J Clin Epidemiol"},{"key":"3012_CR64","unstructured":"LimeSurvey. [cited 17 May 2023]. Available from: https:\/\/www.limesurvey.org\/"},{"issue":"7","key":"3012_CR65","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jclinepi.2010.02.006","volume":"63","author":"LB Mokkink","year":"2010","unstructured":"Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63(7):737\u201345.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"3012_CR66","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000515317","volume":"50","author":"HB Burks","year":"2021","unstructured":"Burks HB, Des Bordes JKA, Chadha R, Holmes HM, Rianon NJ. Quality of life assessment in older adults with dementia: a systematic review. Dement Geriatr Cogn Disord. 2021;50(2):103\u201310.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"2","key":"3012_CR67","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s11136-019-02333-3","volume":"29","author":"AW Griffiths","year":"2020","unstructured":"Griffiths AW, Smith SJ, Martin A, Meads D, Kelley R, Surr CA. Exploring self-report and proxy-report quality-of-life measures for people living with dementia in care homes. Qual Life Res. 2020;29(2):463\u201372.","journal-title":"Qual Life Res"},{"key":"3012_CR68","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ctcp.2017.08.003","volume":"29","author":"J Alcantara","year":"2017","unstructured":"Alcantara J, Ohm J, Alcantara J. Comparison of pediatric self reports and parent proxy reports utilizing PROMIS: Results from a chiropractic practice-based research network. Complement Ther Clin Pract. 2017;29:48\u201352.","journal-title":"Complement Ther Clin Pract"},{"issue":"7","key":"3012_CR69","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.jclinepi.2003.11.013","volume":"57","author":"AJ Janse","year":"2004","unstructured":"Janse AJ, Gemke RJBJ, Uiterwaal CSPM, Van Der Tweel I, Kimpen JLL, Sinnema G. Quality of life: patients and doctors don\u2019t always agree: a meta-analysis. J Clin Epidemiol. 2004;57(7):653\u201361.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"3012_CR70","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/13668250500488660","volume":"31","author":"Y Lunsky","year":"2006","unstructured":"Lunsky Y, Bramston P. A preliminary study of perceived stress in adults with intellectual disabilities according to self-report and informant ratings. J Intellect Dev Disabil. 2006;31(1):20\u20137.","journal-title":"J Intellect Dev Disabil"},{"issue":"2","key":"3012_CR71","doi-asserted-by":"publisher","first-page":"eabb1703","DOI":"10.1126\/sciadv.abb1703","volume":"7","author":"PS Cheah","year":"2021","unstructured":"Cheah PS, Prabhakar S, Yellen D, Beauchamp RL, Zhang X, Kasamatsu S, et al. Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberin. Sci Adv. 2021;7(2):eabb1703.","journal-title":"Sci Adv"},{"key":"3012_CR72","doi-asserted-by":"publisher","first-page":"834628","DOI":"10.3389\/fpsyt.2022.834628","volume":"13","author":"TM Heunis","year":"2022","unstructured":"Heunis TM, Bissell S, Byars AW, Capal JK, Chambers N, Cukier S, et al. Empowering families through technology: a mobile-health project to reduce the TAND identification and treatment gap (TANDem). Front Psychiatry. 2022;13:834628.","journal-title":"Front Psychiatry"},{"issue":"2","key":"3012_CR73","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ymgme.2020.03.008","volume":"130","author":"LA Adang","year":"2020","unstructured":"Adang LA, Gavazzi F, Jawad AF, Cusack SV, Kopin K, Peer K, et al. Development of a neurologic severity scale for Aicardi Gouti\u00e8res Syndrome. Mol Genet Metab. 2020;130(2):153\u201360.","journal-title":"Mol Genet Metab"},{"issue":"12","key":"3012_CR74","doi-asserted-by":"publisher","first-page":"e1530","DOI":"10.1002\/mgg3.1530","volume":"8","author":"A Heaney","year":"2020","unstructured":"Heaney A, Wilburn J, Rouse M, Langmead S, Blakeley JO, Huson S, et al. The development of the PlexiQoL: a patient-reported outcome measure for adults with neurofibromatosis type 1-associated plexiform neurofibromas. Mol Genet Genomic Med. 2020;8(12):e1530.","journal-title":"Mol Genet Genomic Med"},{"issue":"1","key":"3012_CR75","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13023-021-01719-2","volume":"16","author":"MC Patterson","year":"2021","unstructured":"Patterson MC, Lloyd-Price L, Guldberg C, Doll H, Burbridge C, Chladek M, et al. Validation of the 5-domain Niemann-Pick type C Clinical Severity Scale. Orphanet J Rare Dis. 2021;16(1):79.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3012_CR76","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s11689-020-09349-8","volume":"13","author":"A Kolevzon","year":"2021","unstructured":"Kolevzon A, Ventola P, Keary CJ, Heimer G, Neul JL, Adera M, et al. Development of an adapted clinical global impression scale for use in angelman syndrome. J Neurodev Disord. 2021;13(1):3.","journal-title":"J Neurodev Disord"},{"issue":"1","key":"3012_CR77","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3899\/jrheum.130813","volume":"41","author":"JF Fries","year":"2014","unstructured":"Fries JF, Witter J, Rose M, Cella D, Khanna D, Morgan-DeWitt E. Item response theory, computerized adaptive testing, and promis: assessment of physical function. J Rheumatol. 2014;41(1):153\u20138.","journal-title":"J Rheumatol"},{"key":"3012_CR78","unstructured":"Dutch TSC Foundation. [cited 2023 May 17]. Available from: http:\/\/www.tscfonds.nl"}],"updated-by":[{"DOI":"10.1186\/s12916-023-03092-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000}}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-03012-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-023-03012-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-03012-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T13:18:42Z","timestamp":1700399922000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-023-03012-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3012"],"URL":"https:\/\/doi.org\/10.1186\/s12916-023-03012-4","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12916-023-03092-2","asserted-by":"object"}]},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,8]]},"assertion":[{"value":"17 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12916-023-03092-2","URL":"https:\/\/doi.org\/10.1186\/s12916-023-03092-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Medical ethical permission for this study was provided at all participating organizations, with the initiating center the Erasmus University Medical Center Rotterdam in the Netherlands (MEC-2018\u20131507). Consent forms to participate were provided, and competency to fill in the questionnaire was assessed by the involved healthcare professional. In case the individual was not mentally competent to decide on participation, the legal representative decided on behalf of that person.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AvE is part of the scientific advisory board, funded by Jazz Pharmaceuticals, and is an investigator in studies of Jazz Pharmaceuticals. PJdV, MdW, and AJ have provided consultancy to Jazz Pharmaceuticals. LtH works at a department with license for distributing the CBCL in Dutch language areas. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"298"}}